Biocon Limited (BOM:532523)
India · Delayed Price · Currency is INR 361.40
+2.90 (0.81%)
At close: Apr 21, 2026
Biocon Employees
Biocon had 16,420 employees as of September 30, 2025. The number of employees increased by 105 or 0.64% compared to the previous year.
Employees
16,420
Change
105
Growth
0.64%
Revenue / Employee
10.25M INR
Profits / Employee
367.97K INR
Market Cap
585.04B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 16,420 | 105 | 0.64% |
| Mar 31, 2024 | 16,315 | -230 | -1.39% |
| Mar 31, 2023 | 16,545 | 1,545 | 10.30% |
| Mar 31, 2022 | 15,000 | 1,500 | 11.11% |
| Mar 31, 2021 | 13,500 | 891 | 7.07% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Aarti Drugs | 1,284 |
| Hester Biosciences | 562 |
| Titan Biotech | 467 |
| Zenotech Laboratories | 228 |
| Hindustan Bio Sciences | 2 |
Biocon News
- 1 day ago - Biocon secures Health Canada approval for Bosaya and Vevzuo biosimilars - Business Upturn
- 1 day ago - Biocon issues reminder for KYC updates to shareholders with physical holdings - Business Upturn
- 9 days ago - Pharma sector stocks fall today, April 13: Biocon falls 2.35%, Cipla down 1.66%, Ajanta Pharma gains 0.77% - Business Upturn
- 14 days ago - Biocon shares jump over 3% after US FDA nod for diabetes drug Dapagliflozin tablets - Business Upturn
- 14 days ago - Biocon receives U.S. FDA approval for Dapagliflozin tablets - Business Upturn
- 15 days ago - Biocon launches Bosaya and Aukelso biosimilars in the U.S. - Business Upturn
- 20 days ago - Pharma sector stocks fall sharply today: Sun Pharma down 4.89%, Aurobindo Pharma falls 4.48%, Biocon drops 4.67% - Business Upturn
- 23 days ago - Biocon changes name of step-down subsidiary to Biocon Biologics Ireland - Business Upturn